These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25855535)

  • 1. Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy.
    Thurik FF; Ait Soussan A; Bossers B; Woortmeijer H; Veldhuisen B; Page-Christiaens GC; de Haas M; van der Schoot CE
    Prenat Diagn; 2015 Aug; 35(8):754-60. PubMed ID: 25855535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of multiplex real-time PCR assay for noninvasive prenatal assessment of fetal RhD status and fetal sex in maternal plasma.
    Ordoñez E; Rueda L; Cañadas MP; Fuster C; Cirigliano V
    Fetal Diagn Ther; 2013; 34(1):13-8. PubMed ID: 23548569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
    Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
    Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
    Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving.
    Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM
    Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy.
    Moise KJ; Gandhi M; Boring NH; O'Shaughnessy R; Simpson LL; Wolfe HM; Baxter JK; Polzin W; Eddleman KA; Hassan SS; Skupski DW; Ryan G; Walker M; Lam G; Brown R; Skoll MA; Robinson C; Sheikh A; Bronsteen R; Plante LA; McLennan G; Chikova A; Paladino T
    Obstet Gynecol; 2016 Dec; 128(6):1340-1346. PubMed ID: 27824757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy.
    Wikman AT; Tiblad E; Karlsson A; Olsson ML; Westgren M; Reilly M
    Obstet Gynecol; 2012 Aug; 120(2 Pt 1):227-34. PubMed ID: 22776962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
    Cardo L; García BP; Alvarez FV
    Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population.
    Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML
    Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
    Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive fetal RhD status determination in early pregnancy.
    Manzanares S; Entrala C; Sánchez-Gila M; Fernández-Rosado F; Cobo D; Martinez E; Molina L; Reche R; Pineda A; Gallo JL
    Fetal Diagn Ther; 2014; 35(1):7-12. PubMed ID: 24335165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
    Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM
    Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal blood group genotyping: present and future.
    Daniels G; Finning K; Martin P; Summers J
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for managing maternal variant RHD alleles in Rhesus D negative obstetric populations during fetal RHD genotyping.
    Hyland CA; Gardener GJ; O'Brien H; Millard G; Gibbons K; Tremellen A; Ochoa-Garay G; Flower RL; Hyett JA
    Prenat Diagn; 2014 Jan; 34(1):56-62. PubMed ID: 24122907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
    Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
    Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark.
    Clausen FB; Steffensen R; Christiansen M; Rudby M; Jakobsen MA; Jakobsen TR; Krog GR; Madsen RD; Nielsen KR; Rieneck K; Sprogøe U; Homburg KM; Baech J; Dziegiel MH; Grunnet N
    Prenat Diagn; 2014 Oct; 34(10):1000-5. PubMed ID: 24860987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.
    Doescher A; Petershofen EK; Wagner FF; Schunter M; Müller TH
    Transfusion; 2013 Feb; 53(2):353-62. PubMed ID: 22691192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
    Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
    BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.